$1.2M EBITDA Sleep Medicine Business in Illinois

Sami Capital is pleased to present an exclusive acquisition opportunity: a physician-led sleep medicine and primary care practice located in the Midwest. With a modern, patient-focused clinic and dual specialty offerings, this practice combines stable primary care revenue with high-margin sleep medicine services. Highlights ● Robust Financial Performance – Annual revenue of $3.0-3.5M with $1.2-1.4M EBITDA, reflecting strong profitability. ● Dual Service Model – Comprehensive sleep medicine care (studies, CPAP therapy, Inspire Therapy) complemented by primary care services. ● Established Patient Base – Consistent demand supported by preventive care, chronic disease management, and sleep disorder referrals. ● Modern Infrastructure – Advanced diagnostic equipment and facilities for in-lab and home sleep studies. ● Leadership – Board-certified sleep and internal medicine physicians want to stay. Investment Opportunity ● High-Margin Specialty – Attractive EBITDA profile through a blend of sleep medicine and primary care. ● Platform or Add-On – Serves as a premier standalone Midwest sleep platform or as a complementary service for multi-specialty groups. ● Growth Levers – Expansion opportunities include adding providers, growing referral networks, telemedicine, and payer optimization. ● Regional Advantage – Located in the Midwest, capturing strong demographics and high prevalence of sleep disorders with referral network in place. Financial Snapshot ● Revenue: $3.0-$3.5M ● EBITDA: $1.2 - $1.4M ● Price: Evaluating Offers Next Steps For a comprehensive financial package, including detailed operational analysis and investment terms, interested parties are invited to execute an NDA. Contact Faisal Sami, M.D. CEO, Sami Capital ###-###-#### redacted Regulatory & Compliance Notice This message highlights a potential healthcare practice opportunity. It is not an offer to sell or a solicitation to buy securities. To protect the interests of all parties, we share only limited details at this stage. Complete information—including financials and operational insights—will be provided exclusively to qualified buyers after signing a standard Non-Disclosure Agreement (NDA). At SamiCapital.co, we make the M&A process straightforward, confidential, and value-driven. Whether you’re a seller looking to maximize the outcome of your life’s work, or a buyer seeking the right healthcare opportunity, our team ensures a smooth, professional, and rewarding transaction. If you’re ready to explore next steps, let’s connect.